SR One Capital Management — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing therapeutics for pattern hair loss in men and women.
BiotechHealthtechWest Hartford, US
John W. Childs(Director)Reid Waldman(Executive Officer, Director)Jane Grant-Kels(Director)Vladimir Coric(Director)Timothy Durso(Executive Officer, Director)
Board seatKatarina Pance· per SEC Form D
South San Francisco, US
Board seatLaetitia SchwabMatthew R. Patterson· per SEC Form D
Creating next generation precision medicines for patients with cancer and inflammatory diseases by targeting key signaling nodes.
BiotechCambridge, US
Valerie Odegard(Director)Jill Carroll(Director)Carl Gordon(Director)Jeffrey Leiden(Director)Charles Baum(Director)Gary D Glick(Executive Officer, Director)
Board seatJill Carroll· per SEC Form D
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.